188 related articles for article (PubMed ID: 29269019)
1. Inhibition of activated factor X by rivaroxaban attenuates neointima formation after wire-mediated vascular injury.
Hara T; Fukuda D; Tanaka K; Higashikuni Y; Hirata Y; Yagi S; Soeki T; Shimabukuro M; Sata M
Eur J Pharmacol; 2018 Feb; 820():222-228. PubMed ID: 29269019
[TBL] [Abstract][Full Text] [Related]
2. Rivaroxaban, a novel oral anticoagulant, attenuates atherosclerotic plaque progression and destabilization in ApoE-deficient mice.
Hara T; Fukuda D; Tanaka K; Higashikuni Y; Hirata Y; Nishimoto S; Yagi S; Yamada H; Soeki T; Wakatsuki T; Shimabukuro M; Sata M
Atherosclerosis; 2015 Oct; 242(2):639-46. PubMed ID: 25817329
[TBL] [Abstract][Full Text] [Related]
3. Targeting Coagulation Factor Xa Promotes Regression of Advanced Atherosclerosis in Apolipoprotein-E Deficient Mice.
Posthuma JJ; Posma JJN; van Oerle R; Leenders P; van Gorp RH; Jaminon AMG; Mackman N; Heitmeier S; Schurgers LJ; Ten Cate H; Spronk HMH
Sci Rep; 2019 Mar; 9(1):3909. PubMed ID: 30846818
[TBL] [Abstract][Full Text] [Related]
4. Regulator of G-Protein Signaling 5 Prevents Smooth Muscle Cell Proliferation and Attenuates Neointima Formation.
Daniel JM; Prock A; Dutzmann J; Sonnenschein K; Thum T; Bauersachs J; Sedding DG
Arterioscler Thromb Vasc Biol; 2016 Feb; 36(2):317-27. PubMed ID: 26663397
[TBL] [Abstract][Full Text] [Related]
5. A direct oral factor Xa inhibitor edoxaban ameliorates neointimal hyperplasia following vascular injury and thrombosis in apolipoprotein E-deficient mice.
Morishima Y; Honda Y
J Thromb Thrombolysis; 2018 Jul; 46(1):95-101. PubMed ID: 29704172
[TBL] [Abstract][Full Text] [Related]
6. Ectopic Fatty Acid-Binding Protein 4 Expression in the Vascular Endothelium is Involved in Neointima Formation After Vascular Injury.
Fuseya T; Furuhashi M; Matsumoto M; Watanabe Y; Hoshina K; Mita T; Ishimura S; Tanaka M; Miura T
J Am Heart Assoc; 2017 Sep; 6(9):. PubMed ID: 28903937
[TBL] [Abstract][Full Text] [Related]
7. Rivaroxaban, a specific FXa inhibitor, improved endothelium-dependent relaxation of aortic segments in diabetic mice.
Pham PT; Fukuda D; Yagi S; Kusunose K; Yamada H; Soeki T; Shimabukuro M; Sata M
Sci Rep; 2019 Aug; 9(1):11206. PubMed ID: 31371788
[TBL] [Abstract][Full Text] [Related]
8. Demeanor of rivaroxaban in activated/inactivated FXa.
Seki K; Mizuno Y; Sakashita T; Nakano S; Tanno J; Okazaki Y; Muramatsu T; Nishimura S; Senbonmatsu T
J Pharmacol Sci; 2017 Mar; 133(3):156-161. PubMed ID: 28314697
[TBL] [Abstract][Full Text] [Related]
9. The factor Xa inhibitor rivaroxaban reduces cardiac dysfunction in a mouse model of myocardial infarction.
Bode MF; Auriemma AC; Grover SP; Hisada Y; Rennie A; Bode WD; Vora R; Subramaniam S; Cooley B; Andrade-Gordon P; Antoniak S; Mackman N
Thromb Res; 2018 Jul; 167():128-134. PubMed ID: 29843086
[TBL] [Abstract][Full Text] [Related]
10. Mineralocorticoid Receptor Deficiency in Macrophages Inhibits Neointimal Hyperplasia and Suppresses Macrophage Inflammation Through SGK1-AP1/NF-κB Pathways.
Sun JY; Li C; Shen ZX; Zhang WC; Ai TJ; Du LJ; Zhang YY; Yao GF; Liu Y; Sun S; Naray-Fejes-Toth A; Fejes-Toth G; Peng Y; Chen M; Liu X; Tao J; Zhou B; Yu Y; Guo F; Du J; Duan SZ
Arterioscler Thromb Vasc Biol; 2016 May; 36(5):874-85. PubMed ID: 26966277
[TBL] [Abstract][Full Text] [Related]
11. Soluble Flt-1 gene transfer ameliorates neointima formation after wire injury in flt-1 tyrosine kinase-deficient mice.
Koga J; Matoba T; Egashira K; Kubo M; Miyagawa M; Iwata E; Sueishi K; Shibuya M; Sunagawa K
Arterioscler Thromb Vasc Biol; 2009 Apr; 29(4):458-64. PubMed ID: 19164801
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of activated factor X; a new pathway in ameliorating carbon tetrachloride-induced liver fibrosis in rats.
Mahmoud NI; Messiha BAS; Abo-Saif AA; Abdel-Bakky MS
J Biochem Mol Toxicol; 2019 May; 33(5):e22287. PubMed ID: 30719803
[TBL] [Abstract][Full Text] [Related]
13. PDE4 inhibition reduces neointima formation and inhibits VCAM-1 expression and histone methylation in an Epac-dependent manner.
Lehrke M; Kahles F; Makowska A; Tilstam PV; Diebold S; Marx J; Stöhr R; Hess K; Endorf EB; Bruemmer D; Marx N; Findeisen HM
J Mol Cell Cardiol; 2015 Apr; 81():23-33. PubMed ID: 25640159
[TBL] [Abstract][Full Text] [Related]
14. Deletion of angiotensin-converting enzyme 2 promotes the development of atherosclerosis and arterial neointima formation.
Sahara M; Ikutomi M; Morita T; Minami Y; Nakajima T; Hirata Y; Nagai R; Sata M
Cardiovasc Res; 2014 Feb; 101(2):236-46. PubMed ID: 24193738
[TBL] [Abstract][Full Text] [Related]
15. Zinc finger protein 191 deficiency attenuates vascular smooth muscle cell proliferation, migration, and intimal hyperplasia after endovascular arterial injury.
Lv L; Zhang J; Wang P; Meng Q; Liang W; Zhang L
J Vasc Surg; 2014 Feb; 59(2):500-9. PubMed ID: 23755975
[TBL] [Abstract][Full Text] [Related]
16. Macrophage-derived IL-18 and increased fibrinogen deposition are age-related inflammatory signatures of vascular remodeling.
Rodriguez-Menocal L; Faridi MH; Martinez L; Shehadeh LA; Duque JC; Wei Y; Mesa A; Pena A; Gupta V; Pham SM; Vazquez-Padron RI
Am J Physiol Heart Circ Physiol; 2014 Mar; 306(5):H641-53. PubMed ID: 24414074
[TBL] [Abstract][Full Text] [Related]
17. C1q/TNF-related protein 1 prevents neointimal formation after arterial injury.
Kanemura N; Shibata R; Ohashi K; Ogawa H; Hiramatsu-Ito M; Enomoto T; Yuasa D; Ito M; Hayakawa S; Otaka N; Murohara T; Ouchi N
Atherosclerosis; 2017 Feb; 257():138-145. PubMed ID: 28131048
[TBL] [Abstract][Full Text] [Related]
18. Thrombospondin-4 ablation reduces macrophage recruitment in adipose tissue and neointima and suppresses injury-induced restenosis in mice.
Lv L; Liang W; Ye M; Zhang J; Zhang H; Xue G; Zhang L
Atherosclerosis; 2016 Apr; 247():70-7. PubMed ID: 26868511
[TBL] [Abstract][Full Text] [Related]
19. Human urine kininogenase attenuates balloon-induced intimal hyperplasia in rabbit carotid artery through transforming growth factor β1/Smad2/3 signaling pathway.
Lan W; Yang F; Li Z; Liu L; Sang H; Jiang Y; Xiong Y; Zhang R
J Vasc Surg; 2016 Oct; 64(4):1074-83. PubMed ID: 26054589
[TBL] [Abstract][Full Text] [Related]
20. Exendin-4, a glucagon-like peptide-1 receptor agonist, attenuates neointimal hyperplasia after vascular injury.
Hirata Y; Kurobe H; Nishio C; Tanaka K; Fukuda D; Uematsu E; Nishimoto S; Soeki T; Harada N; Sakaue H; Kitagawa T; Shimabukuro M; Nakaya Y; Sata M
Eur J Pharmacol; 2013 Jan; 699(1-3):106-11. PubMed ID: 23220706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]